Abbvie Inc (NYSE:ABBV)
| 132.80 BATS BZX Real-Time Price As of 9:41am ET |  -5.16 / -3.74%Today’s Change | 131.32 Today|||52-Week Range 168.11 | -17.83% Year-to-Date |
Latest ABBV News | Press Releases
Today’s Trading
| Previous close | 137.96 |
| Today’s open | 135.26 |
| Day’s range | 131.32 - 135.26 |
| Volume | 32,596 |
| Average volume (3 months) | 5,907,415 |
| Market cap | $242.7B |
Data as of 9:42am ET, 06/01/2023
Growth & Valuation
| Earnings growth (last year) | +2.68% |
| Earnings growth (this year) | -20.10% |
| Earnings growth (next 5 years) | -0.50% |
| Revenue growth (last year) | +3.30% |
| P/E ratio | 32.5 |
| Price/Sales | 4.95 |
| Price/Book | 14.11 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | -0.94 | -1.29% |
| PFEPfizer | -0.18 | -0.47% |
| NVONovo Nordisk | -2.54 | -1.58% |
| MRKMerck | -0.44 | -0.40% |
Data as of 9:41am ET, 06/01/2023
Financials
| Next reporting date | July 28, 2023 |
| EPS forecast (this quarter) | $2.92 |
| Annual revenue (last year) | $58.1B |
| Annual profit (last year) | $11.8B |
| Net profit margin | 20.29% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters North Chicago, Illinois |
Forecasts
